Spyridon Siafis

206 posts

Spyridon Siafis banner
Spyridon Siafis

Spyridon Siafis

@SiafisS

Clinical scientist @TU_Muenchen | Bridging evidence-based and translational medicine to improve mental health | Hobbyist runner | Views my own.

Katılım Şubat 2017
736 Takip Edilen159 Takipçiler
Spyridon Siafis retweetledi
Yuki Furukawa | 古川 由己
抗精神病薬の臨床試験データを調べ直し、「adverse eventによる脱落」 として報告されている脱落の過半数が精神症状の悪化による脱落であり、「adverse eventによる脱落」が抗精神病薬の副作用の評価指標としては不適切であることがわかりました。 doi.org/10.1016/j.euro…
日本語
0
2
10
400
Spyridon Siafis retweetledi
Yuki Furukawa | 古川 由己
メタアナリシスの実施だけでなく、GRADE評価も補助してくれるようにしました。メタアナツールの中で一番便利なはず yukifurukawa.jp/pmatools/
日本語
1
16
96
5.4K
Spyridon Siafis retweetledi
Nature Reviews Disease Primers
Nature Reviews Disease Primers@DiseasePrimers·
Our NEW Primer on Schizophrenia is live today! By Leucht, Siafis, McGrath, McGorry, Howes, Tamminga, Carr, Bighelli, Schneider-Thoma, Priller, Davis. Check it out here: nature.com/articles/s4157…
English
0
6
17
1.6K
Spyridon Siafis retweetledi
Edoardo G. Ostinelli
Edoardo G. Ostinelli@EGOstinelli·
1/ 📢 New research: we’ve conducted the most comprehensive analysis of treatments for ADHD in adults, including pharmacological, psychological, and neurostimulation approaches. Here’s what we found — and what it means for treatment decisions. 🧵 thelancet.com/journals/lanps…
English
7
47
134
19.2K
のむ
のむ@nomuranobuyuki·
ニュルンベルクに向けてまっすぐ南下せず、謎の迂回路を通るのが謎だった。
日本語
1
0
1
72
Spyridon Siafis retweetledi
GALENOS
GALENOS@GALENOS_Global·
GALENOS wants to hear from you! What are the research questions you want answered about anxiety, depression and psychosis? We want to hear from researchers, clinicians & people with lived experience from all around the world. Fill out the survey here👇 docs.google.com/forms/d/e/1FAI…
English
0
8
11
1K
Spyridon Siafis retweetledi
Orestis Efthimiou
Orestis Efthimiou@oremiou·
Interested in doing a PhD in biostatistics??? We are hiring!!! Come to Bern to work in the project “Evidence synthesis methods to predict personalized treatment effects” funded by the @snsf_ch Details on how to apply in the link ohws.prospective.ch/public/v1/jobs…
English
0
14
21
2.5K
Spyridon Siafis retweetledi
Andrea Cipriani
Andrea Cipriani@And_Cipriani·
Do you want to learn how to carry out & publish a network meta-analysis? Come to @UniofOxford (23-25 Jun 2025) & join our NMA course with hands-on statistics, writing sessions & tips for publication oxforduniversitystores.co.uk/conferences-an… Discounted fees for students/NHS staff & junior academics
English
1
17
44
6.9K
Spyridon Siafis retweetledi
Rob_McCutcheon
Rob_McCutcheon@rob_mccutcheon·
Using a population rather than case control sample massively reduces impact of CNVs on psych disorders. 22q del associated with HR of 3 for schizophrenia (rather than 80 in case-con), and 22dup not found to be protective jamanetwork.com/journals/jamap…
Rob_McCutcheon tweet media
English
0
4
5
1.7K
Spyridon Siafis retweetledi
Nathan Huneke
Nathan Huneke@NathanHuneke·
Placebo response varies substantially in size across mental disorders Correlates of ⬆️ placebo responses in multiple disorders includes later publication year (except ADHD), younger age, more trial sites, larger samples, increased baseline severity & active tx effect size 🧵👇
Nathan Huneke tweet mediaNathan Huneke tweet media
English
3
8
24
2.3K
Spyridon Siafis retweetledi
Nathan Huneke
Nathan Huneke@NathanHuneke·
From our umbrella review, just published in @molpsychiatry. This is the largest synthesis to date of placebo and treatment response across mental disorders in pharmacological and neurostimulation RCTs nature.com/articles/s4138… Some thoughts...
Nathan Huneke tweet media
English
1
2
7
891
Spyridon Siafis retweetledi
Marios Georgakis
Marios Georgakis@MariosGeorgakis·
🚨Postdoc Opening🚨 We're seeking a skilled scientist to lead research in multiomics❗️ Join our excellent interdisciplinary team👇in our efforts to tackle pressing challenges in cardiovascular disease Lab: georgakis-lab.isd-muc.de Position: findapostdoc.com/search/Job-Det… Please RT!
Marios Georgakis tweet media
English
1
18
27
5.6K